Dialysis Efficiency and Transporter Evaluation Computational Tool in Peritoneal Dialysis
Launched by TUEN MUN HOSPITAL · Feb 19, 2025
Trial Information
Current as of July 23, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The DETECT-PD (Dialysis Efficiency and Transporter Evaluation Computational Tool in Peritoneal Dialysis) study is a double-blind, prospective diagnostic test (correlation) study designed to evaluate the feasibility and effectiveness of artificial intelligence (AI) in predicting peritoneal transporter status and dialysis efficiency in patients undergoing peritoneal dialysis (PD). The study aims to develop a computational model that leverages clinical, biochemical, and peritoneal transport data to provide a non-invasive and efficient assessment tool, ultimately improving dialysis management a...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18 years or older
- • Diagnosis of end-stage renal failure requiring peritoneal dialysis as renal replacement therapy
- • Ability to give informed consent and comply with study procedures.
- Exclusion Criteria:
- • History of hernia or peritoneal leak, including pleuroperitoneal fistula (PPF), patent processus vaginalis (PPV) and retroperitoneal leak
- • Ongoing PD peritonitis with or without antibiotic therapy
- • Just finished PD peritonitis antibiotic treatment within recent 4 weeks
- • Pregnancy
- • Patient refusal
About Tuen Mun Hospital
Tuen Mun Hospital is a leading healthcare institution dedicated to providing high-quality medical services and advancing clinical research. As a key player in the Hong Kong healthcare system, the hospital is committed to enhancing patient care through innovative treatments and evidence-based practices. By sponsoring clinical trials, Tuen Mun Hospital aims to contribute to the development of new therapies and improve health outcomes for diverse patient populations. With a focus on collaboration and ethical research practices, the hospital strives to foster a culture of scientific inquiry and excellence in patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tuen Mun, , Hong Kong
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported